- 2024.
- 2023.
- 2022.
- 2021.
- 2020.
- 2019.
- 2018.
- 2017.
- 2016.
- 2015.
- 2014.
- 2013.
- 2012.
- 2011.
- 2010.
- 2009.
- 2008.
- 2007.
- 2006.
- 2005.
- 2004.
- 2003.
- 2002.
- 2001.
- 2000.
- 1999.
- 1998.
- 2024.
- 2023.
- 2022.
- 2021.
- 2020.
- 2019.
- 2018.
- 2017.
- 2016.
- 2015.
- 2014.
- 2013.
- 2012.
- 2011.
- 2010.
- 2009.
- 2008.
- 2007.
- 2006.
- 2005.
- 2004.
- 2003.
- 2002.
- 2001.
- 2000.
- 1999.
- 1998.
2024.
-
- Apr.10.2024 Corporate
- Support for Earthquake Relief Efforts in Eastern Taiwan
-
- Apr.05.2024 Corporate
- Announcement on Changes of the Board of Directors, Audit & Supervisory Board Members and Corporate Officers
-
- Mar.27.2024 Corporate
- Ono Announces General Sponsorship for the “Theme Weeks” as Bronze Partner, at the Expo 2025 Osaka, Kansai, Japan
-
- Mar.05.2024 Corporate
- ONO Receives Excellence Award at the Nikkei Integrated Report Award 2023
-
- Jan.11.2024 Corporate
- Notice of Changes in Representative Directors
-
- Jan.09.2024 Corporate
- Support for Disasters Caused by the 2024 Noto Peninsula Earthquake
2023.
-
- Dec.01.2023 Corporate
- Ono Expands Investment in Ono Venture Investment Fund I, L.P. to US$200 Million
-
- Oct.26.2023 Corporate
- Notice on the Recipients of the “Osamu Hayaishi Memorial Scholarship for Study Abroad” of the FY2024 Japanese Biochemical Society
-
- Oct.02.2023 Corporate
- Ono Starts the Operation of Global Human Resources System
-
- Jul.25.2023 Corporate
- Settlement Agreement over lawsuits on PD-L1 and CTLA-4 antibody patents with AstraZeneca
-
- Jul.18.2023 Corporate
- ONO and AIXs Jointly Developed an AI System for Topic Extraction Analysis of Medical Articles
-
- Jun.30.2023 Corporate
- Michiteku, a subsidiary of Ono Pharmaceutical Acquired Shares of Nekojitadou Inc., a Kansai Electric Power Group Company
-
- Jun.07.2023 Corporate
- Notice concerning the Establishment of OPhrs Co., Ltd.
-
- Jun.06.2023 Corporate
- Implementation of Generative AI Across the Ono Pharmaceutical Group
-
- Apr.14.2023 Corporate
- Initiatives to Strengthen Compliance Management System
-
- Apr.07.2023 Corporate
- Notice regarding Complete Settlement of Lawsuit on Patents relating to Anti-PD-1/PD-L1 Antibody
-
- Apr.07.2023 Corporate
- Announcement on Changes of the Board of Directors, Audit & Supervisory Board Members and Corporate Officers
-
- Feb.15.2023 Corporate
- Support for Relief Efforts in the Earthquake in Turkey and Syria
-
- Jan.31.2023 Corporate
- Notice Concerning the Establishment of “Ono Pharma Oncology, Immunology, Neurology Research Foundation,” a General Incorporated Foundation
-
- Jan.16.2023 Corporate
- Notice concerning the Start of Joint Transportation in the Domestic Distribution of Prescription Pharmaceuticals
-
- Jan.13.2023 Corporate
- Notice concerning Certification as a “DX Certified Business Operator” Stipulated by the Ministry of Economy, Trade and Industry
2022.
-
- Nov.16.2022 Corporate
- Notice Concerning the Establishment of Michiteku Co., Ltd.
-
- Nov.11.2022 Corporate
- Ono and NS Solutions Jointly Build “OASIS”, an Infrastructure for Utilizing Integrated Data
-
- Oct.20.2022 Corporate
- Ono Pharma UD Co., Ltd. Certified as a Special Subsidiary to Promote Employment of Persons with Disabilities
-
- Oct.13.2022 Corporate
- Notice on Recipients of the “Osamu Hayaishi Memorial Scholarship for Study Abroad” of the FY2023 Japanese Biochemical Society
-
- Jul.19.2022 Corporate
- Notice concerning the Start of Investment Business of Ono Digital Health Investment, GK
-
- May.11.2022 Corporate
- Notice regarding Partial Amendments to the Articles of Incorporation
-
- May.11.2022 Corporate
- Announcement on the Revision of Remuneration System for Members of the Board of Directors
-
- Apr.06.2022 Corporate
- Announcement on Changes of the Board of Directors and Corporate Officers
-
- Apr.01.2022 Corporate
- Notice concerning the Establishment of Ono Pharma UD Co., Ltd.
-
- Apr.01.2022 Corporate
- Initiation of Providing "Fukusapo", an Adverse Drug Reaction Management Supporting Tool for Patients Receiving Treatment with Immune Checkpoint Inhibitors
-
- Mar.18.2022 Corporate
- Notice regarding the Reorganization of Research Bases
-
- Feb.28.2022 Corporate
- Filing of Patent Infringement Suit against AstraZeneca K.K.
-
- Feb.24.2022 Corporate
- Notice regarding Collaboration between Ono and Maruha Nichiro in the Field of Health Foods
2021.
-
- Dec.16.2021 Corporate
- Notice regarding Investment to BMG, Inc.
-
- Dec.14.2021 Corporate
- ONO Announces the Foundation of “ONO Pharmaceutical and Dr. Honjo Honorary Research Fund”
-
- Nov.12.2021 Corporate
- ONO Announces the Settlement of Litigation Raised by Dr. Honjo
-
- Nov.01.2021 Corporate
- Notice on the Selection to Apply to New Market Segment “Prime Market” on the Tokyo Stock Exchange
-
- Oct.19.2021 Corporate
- Notice on Decision of Recipients of the "Osamu Hayaishi Memorial Scholarship for Study Abroad" of the FY2022 Japanese Biochemical Society
-
- Aug.06.2021 Corporate
- (Update) Notice on Investigation Results by the Investigation Committee and Future Measures
-
- Jul.02.2021 Corporate
- Notice on Suspicious Emails Disguised as Our Company
-
- Jun.29.2021 Corporate
- Judgment against our employees
-
- May.11.2021 Corporate
- Announcement on Partial Changes of Members of the Board of Directors, Audit & Supervisory Board Members and Corporate Officers
-
- Apr.27.2021 Corporate
- Announcement of New Office Establishment of U.S. Subsidiary (ONO PHARMA USA, INC.)
-
- Apr.05.2021 Corporate
- Announcement on Changes of Members of the Board of Directors, Audit & Supervisory Board Members and Corporate Officers
-
- Feb.26.2021 Corporate
- ONO Entered Sponsorship Agreements with LabCentral and MBC BioLabs
-
- Feb.17.2021 Corporate
- Statement concerning Prosecution of Employees
-
- Feb.01.2021 Corporate
- Notice concerning the Establishment of Ono Pharma Healthcare Co., Ltd.
-
- Jan.29.2021 Corporate
- Statement concerning Arrest of Employees
-
- Jan.12.2021 Corporate
- Notice on the Adopter of the "Osamu Hayaishi Memorial Scholarship for Study Abroad" of the FY2021 Japanese Biochemical Society
-
- Jan.05.2021 Corporate
- Notice on renewal of Ono’s official corporate website
2020.
-
- Jul.06.2020 Corporate
- Notice regarding Filing an Appeal for a Lawsuit against the Company(112 KB)
-
- May.12.2020 Corporate
- Ono establishes a specified subsidiary and a local subsidiary in the US(117 KB)
-
- Apr.08.2020 Corporate
- Announcement on Election of Provisional Audit & Supervisory Board Member (Temporary Acting Audit & Supervisory Board Member)(132 KB)
-
- Apr.06.2020 Corporate
- Announcement on Candidates of Members of the Board of Directors, Members of Audit & Supervisory Board and Corporate Officers, and Resignation of Audit & Supervisory Board Member(117 KB)
2019.
-
- Jul.17.2019 Corporate
- Completion of Yamaguchi Plant, a New Manufacturing Plant(128 KB)
-
- May.22.2019 Corporate
- Ono's Statement in response to the Press Reports with respect to PD-1 Related Patents(36 KB)
-
- Apr.04.2019 Corporate
- Announcement on Candidates of Members of Board of Directors, Members of Audit & Supervisory Board and Corporate Officers(82 KB)
2018.
-
- Aug.21.2018 Corporate
- Announcement of Expansion of Initiatives to Return the Allowances Corresponding to Overtime Work Reduced through Work Style Reform to Employees and Society(103 KB)
-
- Apr.05.2018 Corporate
- Announcement on Candidates of Members of the Board of Directors and Corporate Officers(101 KB)
-
- Mar.01.2018 Corporate
- Completion of a New Tokyo Building(208 KB)